TECHNOLOGY
AI Can’t Create What It Doesn’t Know: Why Inputs Matter
AI can analyse evidence faster than ever, but primary research with customers still creates the evidence pharmaceutical companies require for strategic decision making, says Dan Barton, Spherix Global Insights.
In the 2000s I participated in the pharmaceutical industry rush to...
The biggest barrier to AI in life sciences isn’t the AI
Only 12% of agentic AI initiatives reached production over the past year. The challenge isn’t the technology, but ensuring AI can operate within highly regulated environments. Natosha McNeal, of agentic platform Camunda, investigates.
Life sciences is not short of ambition...
Investment in rare disease biotechs rises, but UK lags behind
Investment in rare disease biotechs has increased following renewal of the FDA’s Priority Review Voucher (PRV) program, but the US remains dominant, says Dan Williams, CEO, SynaptixBio.
In February this year the PRV program was signed into law and will...
East of England biotechs break into UK’s top 10 fastest-growing companies Â
The region claims eight spots in the country’s top 100, with six in its thriving healthcare sector.
The East of England has cemented its position as one of Europe’s leading life sciences clusters, with six healthcare firms placing in the...
The nanoscale device that behaves like a neuron
The structure - made from inorganic material - could be used to improve artificial retinas and make AI more efficient.
McGill University researchers have developed a light-detecting nanoscale structure that mimics how a neuron processes information.
The neuron-like behaviour emerges from...
Global ‘superbug brain’ to fight antimicrobial resistance
The Fleming Initiative, a partnership between Imperial College London and Imperial College Healthcare NHS Trust, has received support from Amazon Web Services (AWS) for its global antimicrobial resistance (AMR) intelligence platform.
The backing, which includes several million pounds worth of...
Innovation network brings bioprinted medicine closer to reality
Millions of people worldwide are losing their sight waiting for corneal transplants. To end this dependence on donors, researchers are working on 3D-printing replacement corneas from stem cells.
A new multimillion-euro international research network has been set up to accelerate...
Diabetes: a protective gel for a future without insulin injections
By developing an innovative gel, UNIGE and HUG researchers have achieved a major breakthrough toward a bioartificial pancreas.
Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in the fight against type...
Living ‘tumour on a chip’ could give best insight into aggressive brain cancer
Scientists are creating a glioblastoma ‘tumour on a chip’– a tiny living system capable of mimicking the key features of the human brain and providing a deeper understanding of how the aggressive brain cancer works.
It is hoped that the...
Growing sustainable rubber from dandelions
A Norwich-based biotech firm is developing sustainable natural rubber from specially engineered dandelions.
QuberTech recently raised £3.4 million in combined grant funding and equity investment to accelerate development of its engineering biology platform and scale commercial operations.
The funding backs QuberTech’s...
Implantable tech could cast new light on bladder cancer treatment
A new implantable device which aims to maximise the effectiveness of light-sensitive drugs could improve future outcomes for bladder cancer patients.
Engineers and cancer scientists from the University of Glasgow have developed the device, which uses wirelessly powered micro-LEDs to...
Manchester team powers next-gen enzyme engineering
A University of Manchester techbio spin-out has secured £5 million to deploy quantum physics, AI modelling, and highly automated labs to power next-gen enzyme engineering.
Imperagen has raised a total of £8.5m to accelerate R&D, expand wet lab capabilities, and...
World first: genome loaded onto quantum computer
Scientists have achieved a world first by loading a complete genome onto a quantum computer – a major step towards using quantum computing to tackle some of biology’s most complex bioinformatic challenges.
The breakthrough comes from a collaboration between...
Delivering versatility without complexity in medical technology
In laboratory instruments, linear motion is where precision meets practicality. Whether positioning a pipette, advancing a fluid, or moving a sample through a preparation workflow, designers need motion that is accurate, repeatable, and dependable over long duty cycles. At...
Injectable gel could help repair damaged swallowing muscles
Biomaterial increases stem cell survival fivefold in preclinical tests, paving the way for advances in regenerative treatments.
A new injectable gel developed by researchers at McGill University and Kyoto University could enable stem cell-based treatments for swallowing disorders.
While stem...
World-first AI model launch for programmable gene insertion
The breakthrough – by biotech Basecamp Research – aims to tackle a longstanding challenge in genetic medicine by developing a new generation of curative cell & gene therapies.Â
These first AI models, capable of programmable gene insertion, offer a new...
How Early Data Drives Better Cell Line Performance
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory expectations. Yet one factor often determines long-term success more than any other: the strength of the data generated in the earliest...
UK’s £400m largest single-use biomanufacturing facility opens in teeside
FUJIFILM Biotechnologies - a global world leader in biologics, vaccines and advanced therapies - has significantly expanded its Teesside site.
FUJIFILM Biotechnologies - a global world leader in biologics, vaccines and advanced therapies - has significantly expanded its Teesside site.
The...
Arbitrating innovation: Resolving IP disputes in life sciences
As biotech and AI converge, arbitration is emerging as the preferred forum for complex intellectual property disputes – particularly when the underlying science defies straightforward explanation or analysis. In this exclusive feature, Bernhard Maier, partner and head of arbitration...
At-home brain stimulation ‘prevents major depression relapse’
Up to 85% of people with depression experience relapse during treatment.
However, a new clinical study has found that at-home brain stimulation therapy helped 75% of patients stay depression-free over six months, solving a major gap in mental health care.
The...
Principal Investigators: The fuel of scientific progress
PIs are crucial to maintaining research integrity, says Dekel Faruhi, VP of Product Adoption at Proofig AI.
The path to becoming a Principal Investigator (PI) usually takes over a decade, beginning with undergraduate studies and culminating in the acquisition of...
AI hallucinations are eroding trust in lab tools – but there are solutions
As scientists and researchers seek to integrate AI more deeply into daily lab workflows, tackling the issue of false or misleading information has become a top priority, says Andrew Wyatt, Chief Growth Officer, Sapio Sciences.
AI is increasingly important for...
How an AI powered implant is rewriting neurological care
The frontier of neurology has begun to think for itself.
The claim follows pioneering brain surgery carried out at King Faisal Specialist Hospital and Research Centre (KFSHRC).
In June 2025, surgeons at the centre, in Riyadh, Saudi Arabia, implanted the Middle...
Why life sciences must build Recall Ready systems now
From paracetamol contamination to failing defibrillators, recent recall events show how fragile response mechanisms remain. Pete Gillett, founder of Marketpoint Recall, explores why life sciences firms must modernise recall operations before regulatory, financial and reputational costs spiral further.
In mid‑2025,...
AI: reimagining AI healthcare
The UK can overcome challenges and harness AI to address the immense pressures on the NHS, says Pratik Maroo, Senior Vice President and Head – Healthcare and Life Sciences, Zensar.
The UK Prime Minister’s Plan for Change focuses on how...
Rules of protein stability are a billion years old
The rules required to make proteins stable are much simpler than previously thought, according to new research.
Published in the journal Science, the study has taken an important step towards learning the rules of protein stability, which may help protein...
Spinal cord injuries healed with bioelectricity
A groundbreaking bioelectric implant has restored movement in rats after spinal cord injuries.
The breakthrough offers new hope for an effective treatment for humans suffering from loss of sensation and function due to spinal cord injury.
The implant is developed by...
Stroke AI software hailed as ‘revolutionary’
An AI software platform has tripled the number of stroke patients achieving functional independence, from 16% to 48%, according to a study by the Royal Berkshire Hospital.
Additional data from the largest real-world evaluation of stroke AI imaging showed that...
Scotland’s total body PET scanner
UK’s world-class imaging platform extends to Scotland.
Scotland’s first total-body scanner is in situ at the Royal Infirmary of Edinburgh, meaning the National PET (Positron Emission Tomography) Imaging Platform network is now operational across the whole UK.
It’s part of a...
The UK’s AI Healthcare Revolution
The Plan for Change focuses on how technology will be used to improve public services. For healthcare, in particular, the government is committed to bringing analogue NHS into the digital age. Pratik Maroo, Senior Vice President and Head –...
